BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

234 related articles for article (PubMed ID: 12908513)

  • 1. Pneumococcal conjugate vaccine: economic issues of the introduction of a new childhood vaccine.
    Ray GT
    Expert Rev Vaccines; 2002 Jun; 1(1):65-74. PubMed ID: 12908513
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Pneumococcal conjugate vaccines. A review.
    Galiza EP; Heath PT
    Minerva Med; 2007 Apr; 98(2):131-43. PubMed ID: 17519855
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Cost-effectiveness analysis of pneumococcal conjugate vaccination in England and Wales.
    Melegaro A; Edmunds WJ
    Vaccine; 2004 Oct; 22(31-32):4203-14. PubMed ID: 15474710
    [TBL] [Abstract][Full Text] [Related]  

  • 4. The pharmacoeconomics of pneumococcal conjugate vaccines in Latin America.
    Giglio N; Micone P; Gentile A
    Vaccine; 2011 Sep; 29 Suppl 3():C35-42. PubMed ID: 21896351
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Issues in pneumococcal disease and pneumococcal conjugate vaccines: highlights of the 27th meeting of ESPID, Brussels, Belgium, June 9-13, 2009.
    Adam D
    Vaccine; 2009 Nov; 27(50):7133-7. PubMed ID: 19883868
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Impact of infant immunization programs with pneumococcal conjugate vaccine in Europe.
    Rose M; Zielen S
    Expert Rev Vaccines; 2009 Oct; 8(10):1351-64. PubMed ID: 19803758
    [TBL] [Abstract][Full Text] [Related]  

  • 7. The epidemiology of childhood pneumococcal disease in the United States in the era of conjugate vaccine use.
    Toltzis P; Jacobs MR
    Infect Dis Clin North Am; 2005 Sep; 19(3):629-45. PubMed ID: 16102653
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Cost effectiveness of adding 7-valent pneumococcal conjugate (PCV-7) vaccine to the Norwegian childhood vaccination program.
    Wisløff T; Abrahamsen TG; Bergsaker MA; Løvoll Ø; Møller P; Pedersen MK; Kristiansen IS
    Vaccine; 2006 Jul; 24(29-30):5690-9. PubMed ID: 16735083
    [TBL] [Abstract][Full Text] [Related]  

  • 9. [Pediatrics. Conjugate anti-pneumoccoccal vaccine: what are the results four years after introduction?].
    Myers C; Gervaix A
    Rev Med Suisse; 2005 Jan; 1(2):142, 144, 146-7. PubMed ID: 15773216
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Cost-effectiveness of pneumococcal conjugate vaccine: an update after 7 years of use in the United States.
    Ray GT; Pelton SI; Klugman KP; Strutton DR; Moore MR
    Vaccine; 2009 Nov; 27(47):6483-94. PubMed ID: 19720366
    [TBL] [Abstract][Full Text] [Related]  

  • 11. A pharmacoeconomic evaluation of 7-valent pneumococcal conjugate vaccine in Canada.
    Lebel MH; Kellner JD; Ford-Jones EL; Hvidsten K; Wang EC; Ciuryla V; Arikian S; Casciano R
    Clin Infect Dis; 2003 Feb; 36(3):259-68. PubMed ID: 12539065
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Convincing or confusing? Economic evaluations of childhood pneumococcal conjugate vaccination--a review (2002-2006).
    Beutels P; Thiry N; Van Damme P
    Vaccine; 2007 Feb; 25(8):1355-67. PubMed ID: 17208339
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Cost-effectiveness of pneumococcal conjugate vaccine: evidence from the first 5 years of use in the United States incorporating herd effects.
    Ray GT; Whitney CG; Fireman BH; Ciuryla V; Black SB
    Pediatr Infect Dis J; 2006 Jun; 25(6):494-501. PubMed ID: 16732146
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Prevenar vaccination: review of the global data, 2006.
    Center KJ
    Vaccine; 2007 Apr; 25(16):3085-9. PubMed ID: 17287048
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Immunogenicity, efficacy, safety and effectiveness of pneumococcal conjugate vaccines (1998-2006).
    Oosterhuis-Kafeja F; Beutels P; Van Damme P
    Vaccine; 2007 Mar; 25(12):2194-212. PubMed ID: 17267077
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Pneumococcal conjugated vaccines: impact of PCV-7 and new achievements in the postvaccine era.
    Dinleyici EC; Yargic ZA
    Expert Rev Vaccines; 2008 Nov; 7(9):1367-94. PubMed ID: 18980540
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Pneumococcal vaccines.
    Ho CF; Lin TY
    Chang Gung Med J; 2005 Nov; 28(11):765-72. PubMed ID: 16422182
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Progress in introduction of pneumococcal conjugate vaccine--worldwide, 2000-2008.
    Centers for Disease Control and Prevention (CDC)
    MMWR Morb Mortal Wkly Rep; 2008 Oct; 57(42):1148-51. PubMed ID: 18946462
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Immunization with the 7-valent conjugate pneumococcal vaccine: impact evaluation, continuing surveillance and future perspectives.
    Bechini A; Boccalini S; Bonanni P
    Vaccine; 2009 May; 27(25-26):3285-90. PubMed ID: 19200829
    [TBL] [Abstract][Full Text] [Related]  

  • 20. [Pneumococcal conjugate vaccine in children].
    Lévy J; Swennen B
    Rev Med Brux; 2004 Sep; 25(4):A219-22. PubMed ID: 15516044
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 12.